Stella-Jones Inc. (OTCMKTS:STLJF) Receives Average Rating of “Buy” from Analysts - Defense World

2022-05-28 13:48:55 By : Mr. Weifeng Gu

Posted by admin on May 25th, 2022

Shares of Stella-Jones Inc. (OTCMKTS:STLJF – Get Rating) have received an average recommendation of “Buy” from the seven brokerages that are presently covering the firm, MarketBeat reports. Three equities research analysts have rated the stock with a buy rating. The average 12 month price target among brokers that have issued ratings on the stock in the last year is $52.00.

Several brokerages recently weighed in on STLJF. TD Securities reduced their target price on shares of Stella-Jones from C$56.00 to C$50.00 in a report on Thursday, May 12th. Royal Bank of Canada reduced their target price on shares of Stella-Jones from C$43.00 to C$40.00 in a report on Thursday, May 12th. Finally, Desjardins raised their target price on shares of Stella-Jones from C$52.00 to C$58.00 in a report on Friday, March 11th.

OTCMKTS STLJF opened at $26.92 on Wednesday. The firm has a 50 day simple moving average of $29.17 and a 200-day simple moving average of $30.95. Stella-Jones has a one year low of $26.36 and a one year high of $38.29.

Stella-Jones Inc produces and markets pressure-treated wood products in Canada and the United States. It offers railway ties and timbers for railroad operators; and wood utility poles for electrical utilities and telecommunication companies. The company also provides residential lumber and accessories to retailers for outdoor applications; industrial products, including bridge and crossing timbers, foundation and marine piling, construction timbers, crane mats, fence posts, and highway guardrail posts; and coal tar-based products.

Receive News & Ratings for Stella-Jones Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Stella-Jones and related companies with MarketBeat.com's FREE daily email newsletter.

Brokerages Expect Tractor Supply (NASDAQ:TSCO) Will Announce Earnings of $3.48 Per Share

TCR2 Therapeutics Inc. (NASDAQ:TCRR) Receives Average Rating of “Buy” from Analysts